Literature DB >> 27543593

Histone deacetylase inhibitors activate NF-κB in human leukemia cells through an ATM/NEMO-related pathway.

Roberto R Rosato, Sarah S Kolla, Stefanie K Hock, Jorge A Almenara, Ankita Patel, Sanjay Amin, Peter Atadja, Paul B Fisher, Paul Dent, Steven Grant.   

Abstract

Entities:  

Year:  2016        PMID: 27543593      PMCID: PMC5016150          DOI: 10.1074/jbc.A109.095208

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  1 in total

1.  Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.

Authors:  Yi-Jin Chen; Wen-Hung Wang; Wan-Yu Wu; Chia-Chi Hsu; Ling-Rung Wei; Sheng-Fan Wang; Ya-Wen Hsu; Chih-Chuang Liaw; Wan-Chi Tsai
Journal:  PLoS One       Date:  2017-08-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.